| Financial Year |
March 31 2023 |
| Monetary Funds |
1,580,440,926.79 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
4,388,342.82 |
| Accounts Receivable |
2,470,739,208.80 |
| Advances to Suppliers |
244,782,485.02 |
| Other Receivables |
270,878,018.93 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,899,520,024.97 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
37,231,018.83 |
| Total Current Assets |
6,742,231,451.07 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
1,449,239,738.85 |
| Investment Properties |
106,289,393.17 |
| Fixed Assetes |
7,632,151,959.18 |
| Under-construction Projects |
1,196,317,009.44 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,301,864,923.77 |
| R&D expenses |
184,430,988.46 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
12,356,877.00 |
| Deferred Income Tax Assets |
93,879,732.37 |
| Other Non-Current Assets |
51,353,009.96 |
| Sub-Total of Non-Current Assets |
12,095,020,563.80 |
| Total Assets |
18,837,252,014.87 |
| Short-Term Loans |
2,693,502,655.27 |
| Trading Financial liabilities |
-- |
| Notes Payable |
527,508,003.75 |
| Accounts Payable |
756,881,420.12 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
242,510,076.34 |
| Taxes Payable |
148,020,148.83 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
1,334,468,125.03 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
850,463,793.12 |
| Other Current Liabilities |
318,625,334.75 |
| Sub-Total of Current Liabilities |
7,032,813,108.56 |
| Long-term Loans |
1,452,217,169.23 |
| Bonds Payable |
1,519,412,334.83 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
17,965,921.00 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
3,226,583,560.88 |
| Total Liabilities |
10,259,396,669.44 |
| Paid-In Capital(Or Share Stock) |
1,180,390,303.00 |
| Capital Surplus |
3,986,785,521.66 |
| Surplus Reserve |
516,195,003.00 |
| LESS:Treasury Stock |
348,472,050.18 |
| Undistributed Profits |
2,544,697,027.44 |
| Minority Stockholder's Interest |
260,460,327.44 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
8,317,395,017.99 |
| Owner's Equity（Stockholder's Equity） |
8,577,855,345.43 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
18,837,252,014.87 |
